Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06799429 · ClinicalTrials.gov registry record · NA

Train Your Brain SC: Exercise for People With Mild-moderate Cognitive Impairments

A NA study of Cognitive Impairment, sponsored by University of South Carolina.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
2
Study locations

NCT06799429: Recruiting NA study of Cognitive Impairment, sponsored by University of South Carolina.

NCT06799429 is a NA study of Cognitive Impairment that is actively recruiting participants, run by University of South Carolina. The registered enrollment target is 50 participants, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06799429, a NA study of Cognitive Impairment, is actively recruiting participants, sponsored by University of South Carolina.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to test a 12-month, twice a week, moderate intensity exercise and coaching program (an in-person group and a distance group) for adults with mild-moderate cognitive impairments living in South Carolina. The main questions it aims to answer are: 1. Is the program practical to conduct, and it is acceptable and enjoyable? The hypothesis is that it will be possible to recruit participants, obtain the desired dosage of moderate intensity fitness and strength training twice a week. 2. Are their changes at 3, 6, 9 and 12 months in endurance, mobility, cognitive function and perception of cognitive function? The hypotheses are that endurance, strength and mobility will improve and cognitive measures will not decline (remain the same or improve). Participants will exercise twice a week in-person with a coach or at a distance location with coaching support for up to 12 months.

Primary Outcome

percent of qualified referrals beginning the program

Conditions Studied

Interventions

  • BEHAVIORAL Supervised in-person group
  • BEHAVIORAL Monitored distance group

Study Locations (2)

South Carolina

  • Arnold School of Public Health - Columbia
  • Sumter YMCA - Sumter

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-11-01
Est. Completion 2026-12
Phase NA
University of South Carolina

157 total trials

What NCT06799429 shows while recruiting

NCT06799429 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Supervised in-person group is the first listed.

NCT06799429 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT06799429 about?

NCT06799429 is a clinical study titled "Train Your Brain SC: Exercise for People With Mild-moderate Cognitive Impairments". The goal of this clinical trial is to test a 12-month, twice a week, moderate intensity exercise and coaching program (an in-person group and a distance group) for adults with mild-moderate cognitive impairments living in South Carolina. The main questions it aims to answer are: 1. Is the program p...

What is the current status of trial NCT06799429?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-11-01. Estimated completion is 2026-12.

What conditions does trial NCT06799429 study?

This clinical trial studies the following conditions: Cognitive Impairment.

What interventions are being tested in trial NCT06799429?

The interventions under investigation include: Supervised in-person group (BEHAVIORAL), Monitored distance group (BEHAVIORAL).

Who is sponsoring clinical trial NCT06799429?

This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06799429 being conducted?

This trial has 2 study locations across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06799429's enrollment target sits among peer trials

50 71st of 105 higher than 33 of 105 other Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06799429, the US trial registry maintained by the National Library of Medicine. NCT06799429 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.